Research article · 2018
Conference abstractPublished 20 Oct 2014
Tumor control by genetically engineered CD8+ and CD4+ T cells
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
This lecture will focus on tumor control by genetically engineered CD8+ and CD4+ T cells. A critical overview of different strategies of cancer gene therapies including adoptive transfer of autologous of CD8+ and CD4+ T cells transduced with genes coding for affinity optimized T cell receptors (TCR) or chimeric antigen receptors (CAR) will be presented. Detailed mechanistic studies will be discussed on how adoptive transfer of tumor-specific CD8+ T cells engineered to express high FasL and IFNγ expression and CAR engineered CD4+ T cells, respectively, mediate complete and permanent tumor eradication. In both cases the transferred T cells reprogrammed the tumor environment from a suppressive one to one supportive for the induction and amplification of endogenous tumor-specific T cell immunity and capable to destroy established tumors. Future perspectives will be discussed, how tumor microenvironments can be manipulated to achieve tumor control by altering balance between immunity and suppression.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 27 Jul 2018
Intramuscular vaccination targeting mucosal tumor draining lymph node enhances integrins-mediated Cd8+ T Cell infiltration to control mucosal tumor growth
Conference abstract · 24 Aug 2015
Engineering customized anti-tumor immune response: Biology of MHC class I restricted TCR engineered CD4 T cells
Conference abstract · 21 Mar 2019
The impact of IR radiation on the induction of bystander killing by genetically engineered ovarian tumor cells: implications for clinical use of cancer vaccines
Conference abstract · 7 Mar 2019
The impact of andgamma;-irradiation on the induction of bystander killing by genetically engineered ovarian tumor cells: Implications for clinical use of cancer vaccines
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Immanuel Luescher”

